Companies

Positioned at the gateway of academic innovation, Integra has invested in game-changing advancements in diverse therapeutic fields that show vast commercial potential, including Oncology, Neurology, Pain & Anesthesia, Infectious Diseases, Inflammation and Ophthalmology. The company holds a portfolio of 11 companies in early to late stages of development